Literature DB >> 4393346

Comparison of the effect of alprenolol and propranolol on specific airway conductance in asthmatic subjects.

C K Connolly, J C Batten.   

Abstract

Alprenolol did not cause a significant fall in the mean of the specific airway conductance in nine asthmatic subjects who did show a significant fall with propranolol. Thus alprenolol is not contraindicated in asthmatic subjects, though it should be used with caution intravenously, as one subject showed a substantial fall in airway conductance at three minutes which recovered within 30 minutes. Until further studies are completed these results should not be applied to bronchitics with increased airway resistance.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4393346      PMCID: PMC1700336          DOI: 10.1136/bmj.2.5708.515

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  4 in total

1.  Alprenolol in angina pectoris. A clinical and ergometric study with a new beta-adrenergic blocking agent.

Authors:  M Arstila; E Iisalo; V Kallio
Journal:  Ann Clin Res       Date:  1969-05

2.  Local effects of beta-adrenergic blocking drugs in asthmatics.

Authors:  H M Beumer
Journal:  Bronches       Date:  1968 Nov-Dec

3.  Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent.

Authors:  J R Anthony; H Jick; D H Spodick
Journal:  Am Heart J       Date:  1969-05       Impact factor: 4.749

4.  Effects of beta-adrenergic receptor blockade on airway conductance and lung volume in normal and asthmatic subjects.

Authors:  P S Richardson; G M Sterling
Journal:  Br Med J       Date:  1969-07-19
  4 in total
  13 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  beta-Adrenoceptor antagonists and respiratory function.

Authors:  D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1978-02       Impact factor: 4.335

3.  Adrenoceptor blocking drugs: clinical pharmacology and therapeutic use.

Authors:  D G McDevitt
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

4.  An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade.

Authors:  C R Kumana; C M Kaye; M Leighton; G E Marlin
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

5.  Beta-adrenergic blocking drugs.

Authors:  J W Paterson
Journal:  Br Med J       Date:  1971-06-12

6.  Risk with -blocking in bronchial asthma.

Authors:  J Gaddie; C Skinner
Journal:  Br Med J       Date:  1972-03-18

7.  Beta-adrenoceptor blocking drugs and partial agonist activity. Is it clinically relevant?

Authors:  D G McDevitt
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

Review 8.  Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.

Authors:  H M Beumer
Journal:  Drugs       Date:  1974       Impact factor: 9.546

9.  Quantitative assessment of bronchial beta-adrenoceptor blockade in man.

Authors:  H R Gribbin; C J Baldwin; A E Tattersfield
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

10.  Assessment of beta-adrenoceptor antagonists in asthmatic patients.

Authors:  R E Ruffin; E L McIntyre; K M Latimer; H E Ward; A J Crockett; J H Alpers
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.